Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38? MAP kinase inhibitor for the treatment of inflammatory diseases.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples